Long COVID Phase 2 Study

Resolve is currently enrolling long covid patients into its phase 2 clinical trial with RSLV-132.  Eligible patients will have been diagnosed with covid by PCR test at lease 6 months previous to enrollment and suffer from severe fatigue.  The study is being conducted at three clinical sites:

Seattle, WA

Knoxville, TN

Pompano Beach, FL

For more information on the study please contact: longcovid@resolvebio.com

ClinicalTrials.gov Identifier: NCT04944121